EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data?
Califano, Raffaele Blackhall, Fiona H Finocchiaro, Giovanna Toschi, Luca Thatcher, Nick Cappuzzo, Federico Crinò, Lucio
Califano, Raffaele
Blackhall, Fiona H
Finocchiaro, Giovanna
Toschi, Luca
Thatcher, Nick
Cappuzzo, Federico
Crinò, Lucio
Citations
Altmetric:
Abstract
Description
Date
2008-07-08
Publisher
Collections
Keywords
Lung Cancer
Tyrosine Kinase Inhibitors
Erlotinib
Placebo-Controlled Trial
Tyrosine Kinase Inhibitors
Erlotinib
Placebo-Controlled Trial
Type
Article
Citation
EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients: how do we interpret the clinical and biomarker data? 2008, 3 (3):173 Targeted Oncology